Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus. 1991

B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

A series of trans-tetrahydro-4-hydroxy-6-[2-(2,3,4,5-substituted-1H-pyrrol-1-yl) ethyl]-2H-pyran-2-ones and their dihydroxy acids were prepared and tested for their ability to inhibit the enzyme HMG-CoA reductase in vitro. Inhibitory potency was found to increase substantially when substituents were introduced into positions three and four of the pyrrole ring. A systematic exploration of structure-activity relationships at these two positions led to the identification of a compound ((+)-33,(+)-(4R)-trans-2-(4-fluororphenyl)-5-(1-methylethyl)-N,3- diphenyl-1- [(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-4- carboxamide) with five times the inhibitory potency of the fungal metabolite compactin.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011753 Pyrones Keto-pyrans.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
January 1991, Journal of medicinal chemistry,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
January 1990, Journal of medicinal chemistry,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
February 1990, Journal of medicinal chemistry,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
January 1990, Journal of medicinal chemistry,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
January 2010, Acta crystallographica. Section E, Structure reports online,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
January 2011, Acta crystallographica. Section E, Structure reports online,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
April 2013, Acta crystallographica. Section E, Structure reports online,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
February 2006, Acta crystallographica. Section C, Crystal structure communications,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
April 2008, Acta crystallographica. Section E, Structure reports online,
B D Roth, and C J Blankley, and A W Chucholowski, and E Ferguson, and M L Hoefle, and D F Ortwine, and R S Newton, and C S Sekerke, and D R Sliskovic, and C D Stratton
January 1990, Journal of medicinal chemistry,
Copied contents to your clipboard!